NCT03118921

Brief Summary

Evaluation of the tolerance and acceptability of the virtual representation of its body image.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 3, 2017

Completed
15 days until next milestone

First Posted

Study publicly available on registry

April 18, 2017

Completed
2 days until next milestone

Study Start

First participant enrolled

April 20, 2017

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2019

Completed
Last Updated

December 28, 2021

Status Verified

December 1, 2021

Enrollment Period

2.5 years

First QC Date

April 3, 2017

Last Update Submit

December 10, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • Self-questionnaire assessing tolerance

    Patients will have to respond to a self-administered questionnaire assessing tolerance

    Day 15

  • Self-questionnaire assessing acceptability

    Patients will have to respond to a self-administered questionnaire assessing acceptability

    Day 15

Secondary Outcomes (3)

  • Feeling of presence

    Day 15

  • Subjective experience by EDI-2 questionnaire

    Day 15

  • Subjective experience by BSQ questionnaire

    Day 15

Study Arms (1)

Virtual reality

EXPERIMENTAL

The first session aims to present the virtual reality material that will be used. The second session will take place 2 weeks after the first session and will consist of the use of the immersion software

Device: Virtual reality

Interventions

The first session aims to present the virtual reality material that will be used. The second session will take place 2 weeks after the first session and will consist of the use of the immersion software.

Virtual reality

Eligibility Criteria

Age16 Years - 40 Years
Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Women, aged between 16 and 40
  • Post-puberty
  • Pure restrictive anorexia nervosa, diagnosis by the DSM-V
  • BMI \<17.5
  • Patient attending an outpatient clinic at the Bohars Psychiatric Hospital in France
  • Having signed the Informed Consent Form
  • For minor patients, signing the form of informed consent of both parents

You may not qualify if:

  • Associated eating disorder (bulimia, or the binge eating / purging form of anorexia nervosa),
  • Psychiatric disorders (characterized depressed, anxiety disorder)
  • Neurological Disorders
  • Mental retardation
  • Abuse or addiction to alcohol
  • Abuse or dependence on psychoactive substances in the previous year.
  • Patient with a protective justice measure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHRU Brest

Brest, 29200, France

Location

MeSH Terms

Conditions

Anorexia

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DEVICE FEASIBILITY
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 3, 2017

First Posted

April 18, 2017

Study Start

April 20, 2017

Primary Completion

October 31, 2019

Study Completion

October 31, 2019

Last Updated

December 28, 2021

Record last verified: 2021-12

Locations